FHA
ALXN

Flagship Harbor Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Flagship Harbor Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-515
Closed -$58K – 1967
2020
Q3 		$58K Hold
515
– – 0.01% 811
2020
Q2 		$57K Hold
515
– – 0.01% 817
2020
Q1 		$46K Hold
515
– – 0.01% 776
2019
Q4 		$56K Buy
515
+15
+3% +$1.6K 0.01% 782
2019
Q3 		$48K Hold
500
– – 0.01% 788
2019
Q2 		$65K Hold
500
– – 0.01% 683
2019
Q1 		$67K Hold
500
– – 0.01% 674
2018
Q4 		$48K Sell
500
-270
-35% -$31.9K 0.01% 734
2018
Q3 		$106K Buy
770
+98
+15% +$12.3K 0.02% 579
2018
Q2 		$83K Buy
+672
New +$78.5K 0.02% 636

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return